Complex chemical concoctions

Journal of Clinical Psychiatry

Volumn 67, Issue 2, 2006, Pages 322-323

  Jefferson, James W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CYCLOSPORIN; CYTOCHROME P450; CYTOCHROME P450 3A4; FELODIPINE; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; MEVINOLIN; VALERIAN;

AREA UNDER THE CURVE; CHEMICAL COMPOSITION; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GRAPEFRUIT JUICE; HERBAL MEDICINE; HUMAN; MEDICAL RESEARCH; NONHUMAN; PHOTOTOXICITY; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 33644829984     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v67n0221     Document Type: Short Survey

References (34)

1. Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum pcrforatum L. Pharmacopsychiatry 1997;30(suppl 2):129-134
2. Singh YN. Kava: an overview. J Ethnopharmacol 1992;37:13-45
3. de los Reyes GC, Koda RT. Determining hyperforin and hypericin content in eight brands of St. John's won. Am J Health Syst Pharm 2002;49:545-547
4. Barrett S. How the Dietary Supplement Health and Education Act of 1994 weakened the FDA. June 8. 2000. Available at: http://www.quackwatch.org/ 02ConsumerProtection/dshea.html. Accessed Nov 2, 2005
5. Angell M, Kassirer JP. Alternative medicine-the risks of untested and unregulated remedies. N Enel J Med 1998;339:839-841
6. Gibson JH, Taylor DA. Can claims, misleading information, and manufacturing issues regarding dietary supplements he improved in the United States? J Pharmacol Exp Ther 2005;314:939-944
7. Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342: 1686-1692
8. Kurz A, Van Baelen B. Ginkgo bilobu compared with cholincsterase inhibitors in the treatment of dementia: a review based on meta-analyses by the Cochrane Collaboration. Dement Geriatr Cogn Disord 2004;18:217-226
9. Kang B-J, Lee S-J, Kim M-D, et al. A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol Clin Exp 2002;17:279-284
10. Vale S. Subarachnoid haemorrhage associated with Gingko biloba [letter]. Lancet 1998;352:36
11. Mac Vie OP, Hamey BA. Vitreous haemorrhage associated with Gingko biloba use in a patient with age related macular disease [letter]. Br J Ophthalmol 2005;89:1378-1379
12. Pittler MH, Ernst E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol 2000;20:84-89
13. Connor KM, Davidson JR. A placebo-controlled study of Kava kava in generalized anxiety disorder. Int Clin Psychopharmacol 2002;17:185-188
14. Clouatre DL. Kava kava: examining new reports of toxicity. Toxicol Lett 2004;150: 85-96
15. Werncke U, Horn O, Taylor DM. How effective is St. John's wort'? the evidence revisited. J Clin Psychiatry 2004;65: 611-617
16. Linde K, Berner M, Egger M, et al. St. John's wort for depression: meta-analysis of randomized controlled trials. Br J Psychiatry 2005;186:99-107
17. Gulick RM, McAuliffe V, Holden-Wiltse J, et al. Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infectcd adults. AIDS Clinical Trials Group Protocols 150 and 258. Ann Int Med 1999;130:510-514
18. Zhou S, Chan E, Pan SQ, et al. Pharmacokinetic interactions of drugs with St. John's wort. J Psychopharmacol 2004;18:262-276
19. Hall SD, Wang Z, Huang SM, et al. The interaction between St. John's wort and an oral contraceptive. Clin Pharmacol Ther 2003;74:525-535
20. Eich-Höchli D, Oppliger R, Golay KP, et al. Methadone maintenance treatment and St. John's wort: a case report. Pharmacopsychiatry 2003;36:35-37
21. Sugimoto K, Ohmori M, Tsuruoka S, et al. Different effects of St. John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001; 70:518-524
22. Ernst E. St. John's wort supplements endanger the success of organ transplantation. Arch Surg 2002;137:316-319
23. Mai I, Bauer S, Perloff ES, et al. Hyperforin content determines the magnitude of the St. John's wort-cyclosporine drug interaction. Clin Pharmacol Ther 2004;76:330-340
24. Jacobs BP, Bent S, Tice JA, et al. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine 2005; 84: 197-207
25. Donovan JL, DeVane CL, Chavin KD, et al. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab Dispos 2004;32:1333-1336
26. Gurley BJ, Gardner SF, Hubbard MA, et al. Cytochromc P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002;72: 276-287
27. Yin OQ, Tomlinson B, Waye MM, et al. Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 2004;14: 841-850
28. Russmann S, Lauterburg BH, Barguil Y, et al. Traditional aqueous kava extracts inhibit cytochrome P450 1A2 in humans: protective effect against environmental carcinogens? [letter] Clin Pharmacol Ther 2005;77:453-454
29. Gurley BJ, Gardner SF, Hubbard MA, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St. John's wort, garlic oil. Panax ginseng, and Ginkgo bilobu. Drugs Aging 2005;22:525-539
30. Hu Z, Yang X, Ho PCL, et al. Herb-drug interactions: a literature review. Drugs 2005;65:1239-1282
31. Satoh H, Yamashita F, Tsujimoto M, et al. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drus Metab Dispos 2005;33:518-523
32. Kane GC, Lipsky JJ. Drug-grapefruit juice interactions. Mayo Clin Proc 2000;75: 933-942
33. Lilja JJ, Raaska K, Neuvonen PJ. Effects of orange juice on the pharmacokinetics of atenolol. Eur J Clin Pharmacol 2005;61: 337-340
34. Hidaka M, Okumura M, Fujita K, et al. Effects of pomegranate juice on human cytochrome P450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metab Dispos 2005;33:644-648